ES2160103T3 - Peptidos que tienen actividad antagonista de taquiquinina. - Google Patents
Peptidos que tienen actividad antagonista de taquiquinina.Info
- Publication number
- ES2160103T3 ES2160103T3 ES93908084T ES93908084T ES2160103T3 ES 2160103 T3 ES2160103 T3 ES 2160103T3 ES 93908084 T ES93908084 T ES 93908084T ES 93908084 T ES93908084 T ES 93908084T ES 2160103 T3 ES2160103 T3 ES 2160103T3
- Authority
- ES
- Spain
- Prior art keywords
- taquiquinina
- antigonist
- peptides
- activity
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010010741 Conjunctivitis Diseases 0.000 abstract 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 102000003141 Tachykinin Human genes 0.000 abstract 1
- 208000024780 Urticaria Diseases 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 206010039083 rhinitis Diseases 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 108060008037 tachykinin Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Crystallography & Structural Chemistry (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/871,723 US5420297A (en) | 1990-10-24 | 1992-04-21 | Peptides having substance P antagonistic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2160103T3 true ES2160103T3 (es) | 2001-11-01 |
Family
ID=25357987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES93908084T Expired - Lifetime ES2160103T3 (es) | 1992-04-21 | 1993-04-09 | Peptidos que tienen actividad antagonista de taquiquinina. |
Country Status (17)
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5654400A (en) * | 1991-10-04 | 1997-08-05 | Fujisawa Pharmaceutical Co., Ltd. | Process for making peptide compounds having tachykinin antagonistic activity |
| WO1994020126A1 (en) * | 1993-03-03 | 1994-09-15 | Fujisawa Pharmaceutical Co., Ltd. | Use of peptides for the manufacture of a medicament |
| WO1995000536A1 (en) * | 1993-06-22 | 1995-01-05 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compounds |
| ATE197157T1 (de) * | 1994-03-17 | 2000-11-15 | Fujirebio Kk | Azapeptid-derivate |
| DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
| WO1998041191A1 (fr) * | 1997-03-14 | 1998-09-24 | Fujisawa Pharmaceutical Co., Ltd. | Preparation pour aerosol |
| US6251919B1 (en) | 1998-02-27 | 2001-06-26 | Warner-Lambert | Heterocyclic substituted aniline calcium channel blockers |
| US6166052A (en) | 1998-03-11 | 2000-12-26 | Warner-Lambert Company | Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers |
| US6399629B1 (en) * | 1998-06-01 | 2002-06-04 | Microcide Pharmaceuticals, Inc. | Efflux pump inhibitors |
| WO2001019848A1 (fr) * | 1999-09-14 | 2001-03-22 | Fujisawa Pharmaceutical Co., Ltd. | Nouveaux procedes de production de composes peptidiques |
| US6437093B1 (en) * | 2000-11-28 | 2002-08-20 | Milkhaus Laboratory, Inc. | Methods of treatment comprising administration of Substance P |
| GB0223077D0 (en) * | 2002-10-04 | 2002-11-13 | Univ Reading The | Treatment of vascular diseases |
| TW200500341A (en) * | 2002-11-12 | 2005-01-01 | Astrazeneca Ab | Novel compounds |
| CN101365700A (zh) * | 2005-11-15 | 2009-02-11 | 沃泰克斯药物股份有限公司 | 可用作激酶抑制剂的氮杂吲唑 |
| EA008737B1 (ru) * | 2005-12-07 | 2007-08-31 | Леонид Андреевич Кожемякин | Средство для профилактики и лечения конъюнктивитов и кератитов различной этиологии (варианты), способ его применения |
| UA105182C2 (ru) | 2008-07-03 | 2014-04-25 | Ньюрексон, Інк. | Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность |
| DE202011000090U1 (de) | 2011-01-14 | 2011-04-21 | E-LEAD ELECTRONIC CO., LTD., Shengang Shiang | Fahrzeug-Audiosystem mit auswechselbarem Plug-In-Computer |
| IT1403659B1 (it) * | 2011-01-28 | 2013-10-31 | Kerakoll S P A | Stucco epossidico a base acquosa |
| NO2729147T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2011-07-04 | 2018-02-03 | ||
| EP2757924B1 (en) * | 2011-09-24 | 2016-12-28 | EnE Holdings Ltd | Beverage system with aeration |
| JP2021514976A (ja) | 2018-02-26 | 2021-06-17 | オスペダーレ・サン・ラッファエーレ・エッセエッレエッレ | 眼痛の治療における使用のためのｎｋ−１拮抗薬 |
| US20230134843A1 (en) | 2020-03-11 | 2023-05-04 | Ospedale San Raffaele S.R.L. | Treatment of stem cell deficiency |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5187156A (en) * | 1988-03-16 | 1993-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| US5164372A (en) * | 1989-04-28 | 1992-11-17 | Fujisawa Pharmaceutical Company, Ltd. | Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same |
| GB8929070D0 (en) * | 1989-12-22 | 1990-02-28 | Fujisawa Pharmaceutical Co | Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same |
| US5321032A (en) * | 1990-02-15 | 1994-06-14 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compounds and pharmaceutical compositions thereof |
| GB9023116D0 (en) * | 1990-10-24 | 1990-12-05 | Fujisawa Pharmaceutical Co | Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same |
-
1992
- 1992-04-21 US US07/871,723 patent/US5420297A/en not_active Expired - Fee Related
-
1993
- 1993-04-09 AT AT93908084T patent/ATE205852T1/de not_active IP Right Cessation
- 1993-04-09 AU AU39045/93A patent/AU674512B2/en not_active Ceased
- 1993-04-09 HU HU9403062A patent/HUT71397A/hu unknown
- 1993-04-09 ES ES93908084T patent/ES2160103T3/es not_active Expired - Lifetime
- 1993-04-09 DE DE69330788T patent/DE69330788T2/de not_active Expired - Fee Related
- 1993-04-09 RU RU94045881A patent/RU2119922C1/ru active
- 1993-04-09 WO PCT/JP1993/000470 patent/WO1993021215A1/en active IP Right Grant
- 1993-04-09 EP EP93908084A patent/EP0640099B1/en not_active Expired - Lifetime
- 1993-04-09 CA CA002118503A patent/CA2118503A1/en not_active Abandoned
- 1993-04-09 JP JP5518181A patent/JPH07505879A/ja active Pending
- 1993-04-09 KR KR1019940703682A patent/KR100250921B1/ko not_active Expired - Fee Related
- 1993-04-15 IL IL10540493A patent/IL105404A/en not_active IP Right Cessation
- 1993-04-15 MX MX9302178A patent/MX9302178A/es not_active IP Right Cessation
- 1993-04-16 TW TW082102911A patent/TW314525B/zh active
- 1993-04-19 ZA ZA932728A patent/ZA932728B/xx unknown
- 1993-04-20 CN CN93105914A patent/CN1041830C/zh not_active Expired - Fee Related
-
1994
- 1994-06-10 US US08/258,456 patent/US5633232A/en not_active Expired - Fee Related
-
1995
- 1995-06-22 HU HU95P/P00398P patent/HU211831A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0640099A1 (en) | 1995-03-01 |
| HU211831A9 (en) | 1995-12-28 |
| KR950700928A (ko) | 1995-02-20 |
| US5633232A (en) | 1997-05-27 |
| MX9302178A (es) | 1994-06-30 |
| AU3904593A (en) | 1993-11-18 |
| HU9403062D0 (en) | 1994-12-28 |
| ZA932728B (en) | 1993-10-28 |
| TW314525B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1997-09-01 |
| JPH07505879A (ja) | 1995-06-29 |
| DE69330788T2 (de) | 2002-05-29 |
| EP0640099B1 (en) | 2001-09-19 |
| KR100250921B1 (ko) | 2000-04-01 |
| IL105404A0 (en) | 1993-08-18 |
| CN1083074A (zh) | 1994-03-02 |
| IL105404A (en) | 1999-11-30 |
| AU674512B2 (en) | 1997-01-02 |
| US5420297A (en) | 1995-05-30 |
| ATE205852T1 (de) | 2001-10-15 |
| WO1993021215A1 (en) | 1993-10-28 |
| CN1041830C (zh) | 1999-01-27 |
| DE69330788D1 (de) | 2001-10-25 |
| HUT71397A (en) | 1995-11-28 |
| RU2119922C1 (ru) | 1998-10-10 |
| CA2118503A1 (en) | 1993-10-28 |
| RU94045881A (ru) | 1996-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2160103T3 (es) | Peptidos que tienen actividad antagonista de taquiquinina. | |
| DE69327541D1 (en) | 4-arylmethyloxymethyl piperidine als tachykinin antagonisten | |
| ATE169001T1 (de) | Substituierte spiro-azaringen als tachykinine rezeptor antagonisten | |
| DE69504300D1 (de) | Gem-bissubstituierte azazyclische tachykinin-antagonisten | |
| GB9409138D0 (en) | Aryl substituted heterocycles | |
| ATE172460T1 (de) | 3-benzoylbenzofuran-derivate als thyroidhormonantagonisten | |
| ATE227722T1 (de) | Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten | |
| MX9701305A (es) | Piperidinas sustituidas novedosas utiles para el tratamiento de enfermedades alergicas. | |
| DE69411424D1 (de) | Zur Behandlung von Erkrankungen des Zentralnervensystems verwendbare Benzimidazole | |
| DE69634678D1 (de) | Verbesserung oder heilung von durch ischämischen krankheiten hervorgerufenen symtomen und dafür verwendbare phenylpiperidinverbingungen | |
| EP0896533A4 (en) | PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS | |
| ATE227293T1 (de) | 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one | |
| DE69626321D1 (de) | Substituierte 4-(1h-benzimidazol-2-yl-amino)piperidine zur behandlung allergischer erkrankungen | |
| EP0774462A4 (en) | HETEROCYCLIC COMPOUND | |
| GB9603137D0 (en) | Therapeutic agents | |
| WO1998031704A3 (en) | Tachykinin antagonists | |
| DE69717969D1 (de) | Substituierte n-methyl-n-(4-(piperidin-1-yl)-2-arylbutyl)-benzamide zur behandlung von allergischen erkrankungen | |
| NO942775L (no) | 3-fenylureido-azepin-2-oner og -benzazepin-2-oner anvendelige som cholecystokinin-antagonister | |
| NO963791L (no) | Peptidderivater | |
| ATE169905T1 (de) | Substituierte alkyldiaminderivate und ihre verwendung als tachykinin antagonisten | |
| ATE145911T1 (de) | Inositol-phosphat-analog als kalzium- antagonistische substanz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 640099 Country of ref document: ES |